Cerus Corp
CERS
CERS: Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
moreShow CERS Financials
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CERS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CERS's directors and management
Government lobbying spending instances
-
$40,000 Jul 20, 2023 Issue: Health Issues Defense Budget/Appropriations
-
$40,000 Apr 20, 2023 Issue: Defense Budget/Appropriations
-
$40,000 Jan 20, 2023 Issue: Defense Government Issues Health Issues Budget/Appropriations
-
$40,000 Oct 20, 2022 Issue: Government Issues Health Issues Budget/Appropriations
-
$40,000 Jul 20, 2022 Issue: Health Issues Budget/Appropriations
-
$40,000 Apr 17, 2022 Issue: Health Issues Budget/Appropriations
-
$40,000 Jan 20, 2022 Issue: None
-
$40,000 Oct 20, 2021 Issue: None
-
$40,000 Jul 20, 2021 Issue: None
-
$40,000 Apr 20, 2021 Issue: None
-
$30,000 Jan 21, 2021 Issue: None
-
$30,000 Oct 20, 2020 Issue: None
-
$30,000 Jul 20, 2020 Issue: None
-
$30,000 Apr 20, 2020 Issue: None
-
$30,000 Jan 21, 2020 Issue: None
-
$30,000 Oct 21, 2019 Issue: Health Issues Budget/Appropriations
-
$30,000 Jul 22, 2019 Issue: Budget/Appropriations
-
$30,000 Apr 22, 2019 Issue: Defense Budget/Appropriations
-
$20,000 Jan 22, 2019 Issue: Budget/Appropriations Defense Health Issues
-
$20,000 Oct 22, 2018 Issue: Government Issues Defense Health Issues Budget/Appropriations
-
$20,000 Jul 20, 2018 Issue: Defense Budget/Appropriations
-
$20,000 Jul 19, 2018 Issue: Health Issues
-
$20,000 Apr 20, 2018 Issue: Budget/Appropriations Defense
-
$20,000 Jan 22, 2018 Issue: Defense Health Issues Budget/Appropriations
-
$20,000 Oct 20, 2017 Issue: Defense Health Issues Budget/Appropriations Government Issues
-
$20,000 Jul 24, 2017 Issue: Budget/Appropriations Defense Health Issues
-
$20,000 Apr 20, 2017 Issue: Budget/Appropriations Defense
-
$20,000 Jan 23, 2017 Issue: Budget/Appropriations Government Issues
-
$20,000 Oct 19, 2016 Issue: Budget/Appropriations Government Issues
-
$20,000 Jul 19, 2016 Issue: Government Issues Budget/Appropriations
-
$20,000 Apr 19, 2016 Issue: Budget/Appropriations Government Issues
-
$20,000 Jan 20, 2016 Issue: Budget/Appropriations Government Issues
-
$20,000 Oct 20, 2015 Issue: Budget/Appropriations
-
$20,000 Jul 20, 2015 Issue: Budget/Appropriations
-
$20,000 Apr 17, 2015 Issue: Budget/Appropriations
-
$20,000 Jan 20, 2015 Issue: Health Issues Budget/Appropriations
-
$20,000 Oct 20, 2014 Issue: Health Issues Budget/Appropriations
-
$20,000 Jul 18, 2014 Issue: Budget/Appropriations
-
$20,000 Apr 18, 2014 Issue: Budget/Appropriations
-
$20,000 Jan 21, 2014 Issue: Budget/Appropriations
-
$20,000 Oct 21, 2013 Issue: Budget/Appropriations
-
$20,000 Jul 19, 2013 Issue: Budget/Appropriations
-
$20,000 Apr 22, 2013 Issue: Government Issues Budget/Appropriations
-
$20,000 Jan 18, 2013 Issue: Budget/Appropriations Government Issues
-
$20,000 Oct 19, 2012 Issue: Government Issues Budget/Appropriations
-
$20,000 Jul 19, 2012 Issue: Budget/Appropriations Government Issues
-
$20,000 Apr 20, 2012 Issue: Government Issues
-
$20,000 Jan 13, 2012 Issue: Defense Budget/Appropriations
-
$20,000 Oct 20, 2011 Issue: Government Issues Defense Budget/Appropriations
-
$20,000 Jul 20, 2011 Issue: Defense Budget/Appropriations Government Issues
-
$20,000 Apr 20, 2011 Issue: Defense Budget/Appropriations Government Issues
-
$20,000 Jan 20, 2011 Issue: Budget/Appropriations Defense
-
$20,000 Oct 19, 2010 Issue: Defense Budget/Appropriations
-
$20,000 Jul 20, 2010 Issue: Defense Budget/Appropriations
-
$20,000 Apr 19, 2010 Issue: Defense Budget/Appropriations
-
$20,000 Jan 19, 2010 Issue: Defense Budget/Appropriations
-
$20,000 Oct 16, 2009 Issue: Defense Budget/Appropriations
-
$20,000 Jul 15, 2009 Issue: Budget/Appropriations Defense
-
$20,000 Apr 17, 2009 Issue: Defense Budget/Appropriations
-
$20,000 Jan 16, 2009 Issue: Budget/Appropriations Defense
-
$20,000 Oct 20, 2008 Issue: Budget/Appropriations Defense
-
$20,000 Jul 09, 2008 Issue: Budget/Appropriations Defense
-
$20,000 Apr 21, 2008 Issue: Budget/Appropriations Defense
-
$60,000 Feb 11, 2008 Issue: Budget/Appropriations Defense
-
$60,000 Aug 08, 2007 Issue: Defense Budget/Appropriations
-
$60,000 Feb 07, 2007 Issue: Budget/Appropriations Defense
-
$60,000 Aug 23, 2006 Issue: Defense Budget/Appropriations
-
$60,000 Feb 28, 2006 Issue: Budget/Appropriations
-
$40,000 Aug 22, 2005 Issue: Defense Budget/Appropriations
-
$40,000 Mar 02, 2005 Issue: Defense Budget/Appropriations
-
$20,000 Aug 23, 2004 Issue: Budget/Appropriations Defense
-
$20,000 Mar 15, 2004 Issue: Budget/Appropriations Defense
-
$40,000 Aug 14, 2003 Issue: Budget/Appropriations Defense
U.S. Patents
New patents grants
-
Patent Title: Systems and methods for treating biological fluids Jan. 17, 2023
-
Patent Title: Kits and methods for preparing pathogen-inactivated platelet compositions Feb. 01, 2022
-
Patent Title: Cryoprecipitate compositions and methods of preparation thereof Aug. 24, 2021
-
Patent Title: Methods for preparing platelet products Nov. 24, 2020
-
Patent Title: Plasma compositions and methods of use thereof Oct. 13, 2020
-
Patent Title: Compositions and methods for improved car-t cell therapies Jun. 23, 2020
-
Patent Title: Pathogen-inactivated red blood cell compositions Jul. 23, 2019
-
Patent Title: Pathogen-inactivated red blood cell compositions Jul. 25, 2017
-
Patent Title: Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix Feb. 16, 2016
-
Patent Title: Quenching methods for red blood cell pathogen inactivation Dec. 02, 2014
-
Patent Title: Quenching methods for red blood cell inactivation process Feb. 02, 2010
Government Contracts
Federal grants, loans, and purchases
- $119,950 2022-01-11 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $56,650 2021-09-10 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $71,360 2021-08-27 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $62,080 2021-08-03 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $59,000 2021-07-26 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $56,160 2020-05-13 Agency: DEPARTMENT OF DEFENSE (DOD)
- $19,800 2020-02-07 Agency: DEPARTMENT OF DEFENSE (DOD)
- $12,000 2019-04-11 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $33,600 2019-04-01 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $53,288 2019-03-22 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $37,760 2019-03-18 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $12,640 2019-02-11 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $16,624 2019-01-30 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $19,020 2018-11-06 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $0 2018-10-16 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $12,000 2018-09-28 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $63,360 2018-08-29 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $6,240 2018-08-22 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $18,860 2018-06-26 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $116,240 2018-06-14 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
Twitter
Followers on CERS's company Twitter account
WallStreetBets
Number of mentions of CERS in WallStreetBets Daily Discussion
CERS News
Recent insights relating to CERS
CNBC Recommendations
Recent picks made for CERS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CERS
Corporate Flights
Flights by private jets registered to CERS